180 related articles for article (PubMed ID: 11708185)
1. Nelfinavir (Viracept).
Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
[No Abstract] [Full Text] [Related]
2. Indinavir (Crixivan).
Res Initiat Treat Action; 2000 Mar; 6(1):28-9. PubMed ID: 11708184
[No Abstract] [Full Text] [Related]
3. Ritonavir (Norvir).
Res Initiat Treat Action; 2000 Mar; 6(1):26-7. PubMed ID: 11708183
[No Abstract] [Full Text] [Related]
4. Amprenavir (Agenerase).
Res Initiat Treat Action; 2000 Mar; 6(1):32-3. PubMed ID: 11708186
[No Abstract] [Full Text] [Related]
5. Saquinavir (Fortovase or Invirase).
Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182
[No Abstract] [Full Text] [Related]
6. [Resistance to protease inhibitors].
Clotet B; Martínez-Picado J; Arrizabalaga J; Ruiz L
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):34-41. PubMed ID: 11428058
[No Abstract] [Full Text] [Related]
7. Bone appetite--using food to boost your Viracept.
Clay PG
Posit Aware; 2003; 14(4):29. PubMed ID: 12951947
[No Abstract] [Full Text] [Related]
8. Viracept and irregular heartbeat warning.
Fornataro K; Jefferys R
Body Posit; 1999 Oct; 12(10):10, 12. PubMed ID: 11366874
[TBL] [Abstract][Full Text] [Related]
9. Twice-daily dosing of Nelfinavir approved.
Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366888
[TBL] [Abstract][Full Text] [Related]
10. Two possible pathways for acquisition of mutations related to nelfinavir resistance.
Sugiura W; Oishi T; Okano A; Matsuda M; Abumi H; Yamada K; Koike M; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takata N; Kakishita E; Higasa S; Kashiwagi S; Shirahata A; Nagai Y
Jpn J Infect Dis; 1999 Aug; 52(4):175-6. PubMed ID: 10592904
[No Abstract] [Full Text] [Related]
11. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
12. Performance of a quadruple combination including nelfinavir plus efavirenz in naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens.
Barreiro P; Oller V; Soriano V; Nuñez M; Rodríguez-Rosado R; González-Lahoz J
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):391-2. PubMed ID: 11317086
[No Abstract] [Full Text] [Related]
13. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
[No Abstract] [Full Text] [Related]
14. Women's nelfinavir (Viracept) trial.
Vazquez E
Posit Aware; 1997; 8(5):15. PubMed ID: 11364633
[TBL] [Abstract][Full Text] [Related]
15. Pregnant pause.
Heidere C
STEP Perspect; 1998; 98(2):5-6. PubMed ID: 11365543
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic junctional bradycardia after treatment with nelfinavir.
Landovitz RJ; Sax PE
Clin Infect Dis; 1999 Aug; 29(2):449-50. PubMed ID: 10476763
[No Abstract] [Full Text] [Related]
17. Nelfinavir: fourth protease inhibitor approved.
Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U
Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.
Johnson M; Nieto-Cisneros L; Horban A; Arasteh K; Gonzalez-Garcia J; Artigas JG; Clotet B; Danise A; Landman R; Proll S; Snowden W; Foreman R; Smith P
HIV Med; 2005 Mar; 6(2):107-13. PubMed ID: 15807716
[TBL] [Abstract][Full Text] [Related]
20. Anti-HIV agents. Nelfinavir levels during pregnancy.
TreatmentUpdate; 2004; 16(3):5-6. PubMed ID: 17216835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
